Model
Edge
Five Prime Therapeutics, Inc.
0001329049
Filing type
3
Filing date
Mar 3, 2019
Updated
Mar 4, 2019 ยท 11:12 AM
Copy reference
Filing
3
Initial Statement of Beneficial Ownership